Draft Standards and Best Practices for Interaction Between Medical Examiner/Coroner and Organ and Tissue Procurement Organizations, 24537 [2012-9842]

Download as PDF Federal Register / Vol. 77, No. 79 / Tuesday, April 24, 2012 / Notices mstockstill on DSK4VPTVN1PROD with NOTICES communication, the date, time, and duration of the communication, the medium of the communication, and a description of the subject matter of the communication (for a collection of communications solely concerning a single business arrangement that is specifically exempted from the reporting requirements of Section IV.C of this Final Judgment, the Settling Defendant may provide a summary of the communications rather than logging each communication individually); and J. Providing to the Department of Justice annually, on or before the anniversary of the entry of this Final Judgment, a written statement as to the fact and manner of the Settling Defendant’s compliance with Sections IV, V, and VII of this Final Judgment. VIII. Compliance Inspection A. For purposes of determining or securing compliance with this Final Judgment, or of determining whether the Final Judgment should be modified or vacated, and subject to any legally recognized privilege, from time to time duly authorized representatives of the Department of Justice, including consultants and other persons retained by the Department of Justice, shall, upon written request of an authorized representative of the Assistant Attorney General in charge of the Antitrust Division, and on reasonable notice to Settling Defendants, be permitted: 1. Access during the Settling Defendants’ office hours to inspect and copy, or at the option of the United States, to require Settling Defendants to provide to the United States hard copy or electronic copies of all books, ledgers, accounts, records, data, and documents in the possession, custody, or control of Settling Defendants, relating to any matters contained in this Final Judgment; and 2. To interview, either informally or on the record, the Settling Defendants’ officers, employees, or agents, who may have their individual counsel present, regarding such matters. The interviews shall be subject to the reasonable convenience of the interviewee and without restraint or interference by Settling Defendants. B. Upon the written request of an authorized representative of the Assistant Attorney General in charge of the Antitrust Division, Settling Defendants shall submit written reports or respond to written interrogatories, under oath if requested, relating to any of the matters contained in this Final Judgment as may be requested. Written reports authorized under this paragraph may, in the sole discretion of the United States, require Settling Defendants to VerDate Mar<15>2010 17:40 Apr 23, 2012 Jkt 226001 conduct, at their cost, an independent audit or analysis relating to any of the matters contained in this Final Judgment. C. No information or documents obtained by the means provided in this Section shall be divulged by the United States to any person other than an authorized representative of the executive branch of the United States, except in the course of legal proceedings to which the United States is a party (including grand jury proceedings), or for the purpose of securing compliance with this Final Judgment, or as otherwise required by law. D. If at the time information or documents are furnished by a Settling Defendant to the United States, the Settling Defendant represents and identifies in writing the material in any such information or documents to which a claim of protection may be asserted under Rule 26(c)(1)(G) of the Federal Rules of Civil Procedure, and the Settling Defendant marks each pertinent page of such material, ‘‘Subject to claim of protection under Rule 26(c)(1)(G) of the Federal Rules of Civil Procedure,’’ then the United States shall give the Settling Defendant ten calendar days notice prior to divulging such material in any civil or administrative proceeding. IX. Retention of Jurisdiction This Court retains jurisdiction to enable any party to apply to this Court at any time for further orders and directions as may be necessary or appropriate to carry out or construe this Final Judgment, to modify any of its provisions, to enforce compliance, and to punish violations of its provisions. X. No Limitation on Government Rights Nothing in this Final Judgment shall limit the right of the United States to investigate and bring actions to prevent or restrain violations of the antitrust laws concerning any past, present, or future conduct, policy, or practice of the Settling Defendants. XI. Expiration of Final Judgment Unless this Court grants an extension, this Final Judgment shall expire five years from the date of its entry. XII. Public Interest Determination Entry of this Final Judgment is in the public interest. The parties have complied with the requirements of the Antitrust Procedures and Penalties Act, 15 U.S.C. 16, including making copies available to the public of this Final Judgment, the Competitive Impact Statement, and any comments thereon and the United States’ responses to PO 00000 Frm 00083 Fmt 4703 Sfmt 9990 24537 comments. Based upon the record before the Court, which includes the Competitive Impact Statement and any comments and response to comments filed with the Court, entry of this Final Judgment is in the public interest. Date: llllllllllllllll Court approval subject to procedures set forth in the Antitrust Procedures and Penalties Act, 15 U.S.C. 16 llllllllll United States District Judge [FR Doc. 2012–9831 Filed 4–23–12; 8:45 am] BILLING CODE P DEPARTMENT OF JUSTICE Office of Justice Programs [OJP (NIJ) Docket No. 1589] Draft Standards and Best Practices for Interaction Between Medical Examiner/ Coroner and Organ and Tissue Procurement Organizations AGENCY: National Institute of Justice, DOJ. Notice and request for comments. ACTION: In an effort to obtain comments from interested parties, the U.S. Department of Justice, Office of Justice Programs, National Institute of Justice, Scientific Working Group for Medicolegal Death Investigation will make available to the general public a document entitled, ‘‘Organ and Tissue Procurement Committee Standards and Best Practices for Interaction Between Medical Examiner/Coroner Offices and Organ Tissue Procurement Organizations’’. The opportunity to provide comments on this document is open to coroner/medical examiner office representatives, law enforcement agencies, organizations, and all other stakeholders and interested parties. Those individuals wishing to obtain and provide comments on the draft document under consideration are directed to the following Web site: http://www.swgmdi.org. DATES: Comments must be received on or before May 12, 2012. FOR FURTHER INFORMATION CONTACT: Patricia Kashtan, by telephone at 202– 353–1856 [Note: this is not a toll-free telephone number], or by email at Patricia.Kashtan@usdoj.gov. SUMMARY: John H. Laub, Director, National Institute of Justice. [FR Doc. 2012–9842 Filed 4–23–12; 8:45 am] BILLING CODE 4410–18–P E:\FR\FM\24APN1.SGM 24APN1

Agencies

[Federal Register Volume 77, Number 79 (Tuesday, April 24, 2012)]
[Notices]
[Page 24537]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-9842]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Office of Justice Programs

[OJP (NIJ) Docket No. 1589]


Draft Standards and Best Practices for Interaction Between 
Medical Examiner/Coroner and Organ and Tissue Procurement Organizations

AGENCY: National Institute of Justice, DOJ.

ACTION: Notice and request for comments.

-----------------------------------------------------------------------

SUMMARY: In an effort to obtain comments from interested parties, the 
U.S. Department of Justice, Office of Justice Programs, National 
Institute of Justice, Scientific Working Group for Medicolegal Death 
Investigation will make available to the general public a document 
entitled, ``Organ and Tissue Procurement Committee Standards and Best 
Practices for Interaction Between Medical Examiner/Coroner Offices and 
Organ Tissue Procurement Organizations''. The opportunity to provide 
comments on this document is open to coroner/medical examiner office 
representatives, law enforcement agencies, organizations, and all other 
stakeholders and interested parties. Those individuals wishing to 
obtain and provide comments on the draft document under consideration 
are directed to the following Web site: http://www.swgmdi.org.

DATES: Comments must be received on or before May 12, 2012.

FOR FURTHER INFORMATION CONTACT: Patricia Kashtan, by telephone at 202-
353-1856 [Note: this is not a toll-free telephone number], or by email 
at Patricia.Kashtan@usdoj.gov.

John H. Laub,
Director, National Institute of Justice.
[FR Doc. 2012-9842 Filed 4-23-12; 8:45 am]
BILLING CODE 4410-18-P